Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of PEGylated Protein Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of PEGylated Protein Therapeuticsmarket, defines the market attractiveness level of PEGylated Protein Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of PEGylated Protein Therapeutics industry, describes the types of PEGylated Protein Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global PEGylated Protein Therapeutics market and the development prospects and opportunities of PEGylated Protein Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global PEGylated Protein Therapeutics market in Chapter 13.
By Player:
Amgen
Horizon Pharma
Roche
AstraZeneca
Pfizer
Leadiant Biosciences
Biogen
UCB
Merck
By Type:
Colony Stimulating Factor
Interferon
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibody
Enzyme
Others
By End-User:
Cancer
Autoimmune Disease
Hepatitis
Multiple Sclerosis
Hemophilia
Gastrointestinal Disorder
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 PEGylated Protein Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 PEGylated Protein Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 PEGylated Protein Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 PEGylated Protein Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise PEGylated Protein Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global PEGylated Protein Therapeutics Consumption (2017-2022)
-
7.2 United States PEGylated Protein Therapeutics Consumption (2017-2022)
-
7.3 Europe PEGylated Protein Therapeutics Consumption (2017-2022)
-
7.4 China PEGylated Protein Therapeutics Consumption (2017-2022)
-
7.5 Japan PEGylated Protein Therapeutics Consumption (2017-2022)
-
7.6 India PEGylated Protein Therapeutics Consumption (2017-2022)
-
7.7 South Korea PEGylated Protein Therapeutics Consumption (2017-2022)
8 Region and Country-wise PEGylated Protein Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global PEGylated Protein Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States PEGylated Protein Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe PEGylated Protein Therapeutics Consumption Forecast (2022-2028)
-
8.4 China PEGylated Protein Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan PEGylated Protein Therapeutics Consumption Forecast (2022-2028)
-
8.6 India PEGylated Protein Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea PEGylated Protein Therapeutics Consumption Forecast (2022-2028)
9 Global PEGylated Protein Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global PEGylated Protein Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Colony Stimulating Factor Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Interferon Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Erythropoietin (EPO) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Recombinant Factor VIII Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Enzyme Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global PEGylated Protein Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Autoimmune Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hepatitis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Hemophilia Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Gastrointestinal Disorder Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Others Consumption and Growth Rate (2017-2022)
10 Global PEGylated Protein Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global PEGylated Protein Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Erythropoietin (EPO) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Enzyme Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global PEGylated Protein Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Autoimmune Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Gastrointestinal Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global PEGylated Protein Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global PEGylated Protein Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global PEGylated Protein Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 PEGylated Protein Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global PEGylated Protein Therapeutics Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen PEGylated Protein Therapeutics Product and Service
-
14.2 Horizon Pharma
-
14.2.1 Horizon Pharma Company Details
-
14.2.2 Horizon Pharma PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Horizon Pharma PEGylated Protein Therapeutics Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche PEGylated Protein Therapeutics Product and Service
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Details
-
14.4.2 AstraZeneca PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca PEGylated Protein Therapeutics Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer PEGylated Protein Therapeutics Product and Service
-
14.6 Leadiant Biosciences
-
14.6.1 Leadiant Biosciences Company Details
-
14.6.2 Leadiant Biosciences PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Leadiant Biosciences PEGylated Protein Therapeutics Product and Service
-
14.7 Biogen
-
14.7.1 Biogen Company Details
-
14.7.2 Biogen PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Biogen PEGylated Protein Therapeutics Product and Service
-
14.8 UCB
-
14.8.1 UCB Company Details
-
14.8.2 UCB PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 UCB PEGylated Protein Therapeutics Product and Service
-
14.9 Merck
-
14.9.1 Merck Company Details
-
14.9.2 Merck PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck PEGylated Protein Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of PEGylated Protein Therapeutics
-
Figure PEGylated Protein Therapeutics Picture
-
Table Global PEGylated Protein Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global PEGylated Protein Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global PEGylated Protein Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global PEGylated Protein Therapeutics Consumption by Country (2017-2022)
-
Figure United States PEGylated Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe PEGylated Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China PEGylated Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan PEGylated Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India PEGylated Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea PEGylated Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global PEGylated Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States PEGylated Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe PEGylated Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China PEGylated Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan PEGylated Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India PEGylated Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea PEGylated Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colony Stimulating Factor Consumption and Growth Rate (2017-2022)
-
Figure Global Interferon Consumption and Growth Rate (2017-2022)
-
Figure Global Erythropoietin (EPO) Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Enzyme Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erythropoietin (EPO) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzyme Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global PEGylated Protein Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global PEGylated Protein Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen PEGylated Protein Therapeutics Product and Service
-
Table Horizon Pharma (Foundation Year, Company Profile and etc.)
-
Table Horizon Pharma PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Pharma PEGylated Protein Therapeutics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche PEGylated Protein Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca PEGylated Protein Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer PEGylated Protein Therapeutics Product and Service
-
Table Leadiant Biosciences (Foundation Year, Company Profile and etc.)
-
Table Leadiant Biosciences PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Leadiant Biosciences PEGylated Protein Therapeutics Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen PEGylated Protein Therapeutics Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB PEGylated Protein Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck PEGylated Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck PEGylated Protein Therapeutics Product and Service
-
